Caris Life Sciences Net Income
| CAI Stock | USD 20.85 0.20 0.95% |
As of the 19th of February, Caris Life shows the Risk Adjusted Performance of (0.04), mean deviation of 2.06, and Standard Deviation of 2.85. Caris Life Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Caris Life Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 18.4 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -253.7 M | -241 M | |
| Net Loss | -324.2 M | -340.4 M | |
| Net Loss | (1.00) | (0.95) | |
| Net Income Per E B T | 0.85 | 0.68 |
Caris | Net Income | Build AI portfolio with Caris Stock |
The Net Income trend for Caris Life Sciences offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Caris Life is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Caris Life's Net Income Growth Pattern
Below is the plot of the Net Income of Caris Life Sciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Caris Life Sciences financial statement analysis. It represents the amount of money remaining after all of Caris Life Sciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Caris Life's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caris Life's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (281.89 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Caris Net Income Regression Statistics
| Arithmetic Mean | (75,425,644) | |
| Coefficient Of Variation | (223.76) | |
| Mean Deviation | 153,779,069 | |
| Median | 26,838,000 | |
| Standard Deviation | 168,774,217 | |
| Sample Variance | 28484.7T | |
| Range | 420M | |
| R-Value | (0.78) | |
| Mean Square Error | 11683.3T | |
| R-Squared | 0.62 | |
| Significance | 0.0002 | |
| Slope | (26,220,531) | |
| Total Sum of Squares | 455755.8T |
Caris Net Income History
Other Fundumenentals of Caris Life Sciences
Caris Life Net Income component correlations
Caris Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Caris Life is extremely important. It helps to project a fair market value of Caris Stock properly, considering its historical fundamentals such as Net Income. Since Caris Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Caris Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Caris Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Trading Companies & Distributors market expansion? Will Caris introduce new products? Factors like these will boost the valuation of Caris Life. Projected growth potential of Caris fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Caris Life's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Caris Life should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Caris Life's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Caris Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Caris Life's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Caris Life.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Caris Life on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Caris Life Sciences or generate 0.0% return on investment in Caris Life over 90 days. Caris Life is related to or competes with Jazz Pharmaceuticals, Avidity Biosciences, Moderna, Cytokinetics, Madrigal Pharmaceuticals, Halozyme Therapeutics, and Abivax SA. CAI International, Inc. operates as a transportation finance company in the United States, Switzerland, France, Korea, S... More
Caris Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Caris Life's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Caris Life Sciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 17.67 | |||
| Value At Risk | (4.91) | |||
| Potential Upside | 3.96 |
Caris Life Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Caris Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Caris Life's standard deviation. In reality, there are many statistical measures that can use Caris Life historical prices to predict the future Caris Life's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (0.25) |
Caris Life February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.24) | |||
| Mean Deviation | 2.06 | |||
| Coefficient Of Variation | (1,494) | |||
| Standard Deviation | 2.85 | |||
| Variance | 8.14 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (0.25) | |||
| Maximum Drawdown | 17.67 | |||
| Value At Risk | (4.91) | |||
| Potential Upside | 3.96 | |||
| Skewness | (0.71) | |||
| Kurtosis | 2.38 |
Caris Life Sciences Backtested Returns
Caris Life Sciences secures Sharpe Ratio (or Efficiency) of -0.0657, which signifies that the company had a -0.0657 % return per unit of risk over the last 3 months. Caris Life Sciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Caris Life's Standard Deviation of 2.85, risk adjusted performance of (0.04), and Mean Deviation of 2.06 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.82, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Caris Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding Caris Life is expected to be smaller as well. At this point, Caris Life Sciences has a negative expected return of -0.2%. Please make sure to confirm Caris Life's kurtosis, and the relationship between the value at risk and rate of daily change , to decide if Caris Life Sciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.46 |
Modest reverse predictability
Caris Life Sciences has modest reverse predictability. Overlapping area represents the amount of predictability between Caris Life time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Caris Life Sciences price movement. The serial correlation of -0.46 indicates that about 46.0% of current Caris Life price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.46 | |
| Spearman Rank Test | -0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 6.07 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Caris Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Caris Life Sciences reported net income of (281.89 Million). This is 208.65% lower than that of the Trading Companies & Distributors sector and 246.37% lower than that of the Industrials industry. The net income for all United States stocks is 149.37% higher than that of the company.
Caris Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Caris Life's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Caris Life could also be used in its relative valuation, which is a method of valuing Caris Life by comparing valuation metrics of similar companies.Caris Life is currently under evaluation in net income category among its peers.
Caris Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Caris Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Caris Life's managers, analysts, and investors.Environmental | Governance | Social |
Caris Fundamentals
| Profit Margin | (0.60) % | ||||
| Operating Margin | (0.48) % | ||||
| Current Valuation | 8.33 B | ||||
| Shares Outstanding | 283.56 M | ||||
| Shares Owned By Insiders | 48.15 % | ||||
| Shares Owned By Institutions | 16.18 % | ||||
| Number Of Shares Shorted | 5.9 M | ||||
| Price To Earning | 17.74 X | ||||
| Price To Sales | 17.55 X | ||||
| Revenue | 412.26 M | ||||
| Gross Profit | 211.38 M | ||||
| EBITDA | (182.95 M) | ||||
| Net Income | (281.89 M) | ||||
| Cash And Equivalents | 38.81 M | ||||
| Cash Per Share | 2.26 X | ||||
| Total Debt | 424.26 M | ||||
| Debt To Equity | 2.41 % | ||||
| Current Ratio | 0.45 X | ||||
| Book Value Per Share | (18.45) X | ||||
| Cash Flow From Operations | (245.2 M) | ||||
| Earnings Per Share | (1.25) X | ||||
| Price To Earnings To Growth | 0.90 X | ||||
| Number Of Employees | 1.77 K | ||||
| Beta | 1.47 | ||||
| Market Capitalization | 7.94 B | ||||
| Total Asset | 343.73 M | ||||
| Retained Earnings | (2.47 B) | ||||
| Working Capital | 50.31 M | ||||
| Current Asset | 131.15 M | ||||
| Current Liabilities | 215.06 M | ||||
| Net Asset | 343.73 M | ||||
| Last Dividend Paid | 1.2 |
About Caris Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Caris Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Caris Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Caris Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is there potential for Trading Companies & Distributors market expansion? Will Caris introduce new products? Factors like these will boost the valuation of Caris Life. Projected growth potential of Caris fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Caris Life's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Caris Life should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Caris Life's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.